Grafting primary human T lymphocytes with cancer-specific chimeric single chain and two chain TCR
- 1 August 2000
- journal article
- Published by Springer Nature in Gene Therapy
- Vol. 7 (16) , 1369-1377
- https://doi.org/10.1038/sj.gt.3301253
Abstract
At the forefront of medicine, Gene Therapy brings you the latest research into genetic and cell-based technologies to treat disease. It also publishes Progress & Prospects reviews and News and Commentary articles, which highlight the cutting edge of the field.Keywords
This publication has 40 references indexed in Scilit:
- Genetic re-targeting of T lymphocyte specifityGene Therapy, 1998
- Regression of Advanced Ovarian Carcinoma by Intraperitoneal Treatment With Autologous TLymphocytes Retargeted by a Bispecific Monoclonal AntibodyJNCI Journal of the National Cancer Institute, 1995
- Treatment of Patients With Metastatic Melanoma With Autologous Tumor-Infiltrating Lymphocytes and Interleukin 2JNCI Journal of the National Cancer Institute, 1994
- New simplified molecular design for functional T cell receptorEuropean Journal of Immunology, 1993
- The roles of CD8 in cytotoxic T lymphocyte functionImmunology Today, 1993
- Restoration of Viral Immunity in Immunodeficient Humans by the Adoptive Transfer of T Cell ClonesScience, 1992
- A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human MelanomaScience, 1991
- The cytoplasmic domain of the T cell receptor ζ chain is sufficient to couple to receptor-associated signal transduction pathwaysCell, 1991
- Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic MelanomaNew England Journal of Medicine, 1988
- RAPID EXPANSION OF ALLOSPECIFIC CYTOTOXIC T CELL CLONES USING NONSPECIFIC FEEDER CELL LINES WITHOUT FURTHER ADDITION OF EXOGENOUS IL2Transplantation, 1984